Phase I Study of Photodynamic Therapy Using Pulsed Dye Laser and Oral Aminolevulinic Acid in Patients With Oral Leukoplakia

Trial Profile

Phase I Study of Photodynamic Therapy Using Pulsed Dye Laser and Oral Aminolevulinic Acid in Patients With Oral Leukoplakia

Discontinued
Phase of Trial: Phase I

Latest Information Update: 04 Nov 2014

At a glance

  • Drugs Aminolevulinic acid (Primary)
  • Indications Leucoplakia; Oropharyngeal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Dec 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 20 May 2010 Planned end date changed from Dec 2008 to Jun 2013 as reported by ClinicalTrials.gov.
    • 29 Jan 2010 Status changed from suspended to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top